Core Insights - Zhendermedical's stock increased by 6.25% to 68.90 CNY per share, with a trading volume of 297 million CNY and a turnover rate of 1.68%, resulting in a total market capitalization of 18.358 billion CNY [1] Company Overview - Zhendermedical, established on August 18, 1994, and listed on April 12, 2018, is located in Shaoxing City, Zhejiang Province. The company specializes in the production, research, and sales of medical dressings [1] - The main revenue composition includes: - Surgical infection control: 43.04% - Basic care: 20.46% - Stoma and modern wound care: 18.59% - Pressure treatment and fixation: 10.75% - Infection control protection: 6.58% - Others: 0.58% [1] Shareholder Insights - Zhendermedical's top circulating shareholder is a fund under China Merchants Fund, specifically the China Merchants Core Competitiveness Mixed A (014412), which increased its holdings by 581,000 shares to a total of 3.4286 million shares, representing 1.29% of circulating shares. The estimated floating profit today is approximately 13.886 million CNY [2] - The fund was established on April 13, 2022, with a latest scale of 2.993 billion CNY. Year-to-date returns are 20.14%, ranking 4429 out of 8161 in its category, while the one-year return is 23.01%, ranking 4129 out of 8021. Since inception, the return is 56.25% [2] Fund Manager Profile - The fund manager for China Merchants Core Competitiveness Mixed A (014412) is Zhu Hongyu, who has a cumulative tenure of 14 years and 154 days. The total asset scale of the fund is 4.964 billion CNY, with the best fund return during his tenure being 54.07% and the worst being -12.86% [3] Fund Holdings - Another fund under China Merchants Fund, the China Merchants Social Responsibility Mixed A (018309), holds 1.367 million shares of Zhendermedical, accounting for 2.96% of the fund's net value, ranking as the tenth largest holding. The estimated floating profit today is approximately 5.5364 million CNY [4] - This fund was established on April 26, 2023, with a latest scale of 974 million CNY. Year-to-date returns are 27.67%, ranking 3282 out of 8161, while the one-year return is 29.91%, ranking 3182 out of 8021. Since inception, the return is 8.49% [4]

Core Viewpoint - Zhendemedical has experienced a significant stock price increase of 38.96% over the past seven days, closing at 59.49 CNY per share with a market capitalization of 15.851 billion CNY [1] Group 1: Company Overview - Zhendemedical, established on August 18, 1994, and listed on April 12, 2018, is located in Shaoxing, Zhejiang Province. The company specializes in the production, research, and sales of medical dressings [1] - The revenue composition of Zhendemedical includes: 43.04% from surgical infection control, 20.46% from basic care, 18.59% from ostomy and modern wound care, 10.75% from pressure treatment and fixation, 6.58% from infection control protection, and 0.58% from other sources [1] Group 2: Shareholder Information - The top circulating shareholder of Zhendemedical is the "Zhaoshang Core Competitiveness Mixed A" fund, which increased its holdings by 581,000 shares to a total of 3.4286 million shares, representing 1.29% of circulating shares. The fund has gained approximately 10.3888 million CNY in floating profit today and 54.2754 million CNY during the seven-day increase [2] - The "Zhaoshang Core Competitiveness Mixed A" fund was established on April 13, 2022, with a current scale of 2.993 billion CNY. It has achieved a year-to-date return of 21.25% and a one-year return of 18.18% [2] Group 3: Fund Manager Information - The fund manager of "Zhaoshang Core Competitiveness Mixed A" is Zhu Hongyu, who has a total tenure of 14 years and 151 days. The fund's total asset scale is 4.964 billion CNY, with the best return during his tenure being 57.7% and the worst being -12.86% [3][5] Group 4: Fund Holdings - Another fund, "Zhaoshang Social Responsibility Mixed A," holds 1.367 million shares of Zhendemedical, accounting for 2.96% of the fund's net value. This fund has gained approximately 4.142 million CNY in floating profit today and 21.6396 million CNY during the seven-day increase [4] - The "Zhaoshang Social Responsibility Mixed A" fund was established on April 26, 2023, with a current scale of 974 million CNY. It has achieved a year-to-date return of 29.24% and a one-year return of 25.23% [4]

Group 1 - The core viewpoint of the news is that Zhendemedical has seen a stock price increase of 5.44%, reaching 43.26 CNY per share, with a total market capitalization of 11.527 billion CNY [1] - Zhendemedical, established on August 18, 1994, specializes in the production, research, and sales of medical dressings, with its main business revenue composition being: surgical infection control 43.04%, basic care 20.46%, ostomy and modern wound care 18.59%, pressure treatment and fixation 10.75%, infection control protection 6.58%, and others 0.58% [1] Group 2 - Zhendemedical is a significant holding in the fund ZheShang Huijin Quantitative Selected Stocks A (011824), which held 44,300 shares in the second quarter, unchanged from the previous period, representing 0.74% of the fund's net value [2] - The fund has achieved a year-to-date return of 27.35% and a one-year return of 60.07%, ranking 2008 out of 4220 and 1427 out of 3820 in its category, respectively [2] Group 3 - The fund manager of ZheShang Huijin Quantitative Selected Stocks A is Chen Gujun, who has been in the position for 5 years and 250 days, with the fund's total asset size at 204 million CNY [3] - During Chen Gujun's tenure, the best fund return was 35.77%, while the worst was -7.57% [3]

Core Viewpoint - Zhendemedical experienced a 5.44% increase in stock price, reaching 43.26 CNY per share, with a trading volume of 135 million CNY and a turnover rate of 1.20%, resulting in a total market capitalization of 11.527 billion CNY [1] Company Overview - Zhendemedical is located in Shaoxing City, Zhejiang Province, and was established on August 18, 1994. The company went public on April 12, 2018. Its main business involves the production, research, and sales of medical dressings [1] - The revenue composition of Zhendemedical includes: - Surgical infection control: 43.04% - Basic care: 20.46% - Stoma and modern wound care: 18.59% - Pressure treatment and fixation: 10.75% - Infection control protection: 6.58% - Others: 0.58% [1] Shareholder Information - Zhendemedical's top circulating shareholder is a fund under China Merchants Fund, specifically the China Merchants Core Competitiveness Mixed A (014412), which increased its holdings by 581,000 shares in the second quarter, totaling 3.4286 million shares, representing 1.29% of circulating shares. The estimated floating profit today is approximately 7.6459 million CNY [2] - The China Merchants Core Competitiveness Mixed A fund was established on April 13, 2022, with a current scale of 2.993 billion CNY. Year-to-date returns are 22.19%, ranking 4235 out of 8173 in its category; the one-year return is 47.73%, ranking 3179 out of 8003; and since inception, the return is 58.91% [2] Fund Manager Information - The fund manager of China Merchants Core Competitiveness Mixed A is Zhu Hongyu, who has a cumulative tenure of 14 years and 133 days. The total asset scale of the fund is 4.964 billion CNY, with the best fund return during his tenure being 57.72% and the worst being -12.86% [3] Fund Holdings - Another fund under China Merchants Fund, the China Merchants Social Responsibility Mixed A (018309), holds 1.367 million shares of Zhendemedical, accounting for 2.96% of the fund's net value, making it the tenth largest holding. The estimated floating profit today is approximately 3.0484 million CNY [4] - The China Merchants Social Responsibility Mixed A fund was established on April 26, 2023, with a current scale of 974 million CNY. Year-to-date returns are 29.77%, ranking 3226 out of 8173; the one-year return is 54.04%, ranking 2634 out of 8003; and since inception, the return is 10.28% [4] Fund Manager Information (Social Responsibility Fund) - The fund manager of China Merchants Social Responsibility Mixed A is also Zhu Hongyu, with the same cumulative tenure and asset scale as mentioned previously [5]

Group 1 - The core viewpoint of the news is the performance and financial metrics of Zhendemedical, which saw a stock price increase of 5.08% to 37.45 CNY per share, with a trading volume of 1.007 billion CNY and a turnover rate of 10.47%, leading to a total market capitalization of 9.979 billion CNY [1] - Zhendemedical, established on August 18, 1994, and listed on April 12, 2018, specializes in the production, research, and sales of medical dressings, with its main business revenue composition being: surgical infection control 43.04%, basic care 20.46%, ostomy and modern wound care 18.59%, pressure treatment and fixation 10.75%, infection control protection 6.58%, and others 0.58% [1] Group 2 - From the perspective of major fund holdings, Xiangcai Fund has a significant position in Zhendemedical, with its Xiangcai Medical Health Mixed A Fund (019958) increasing its holdings by 10,000 shares to a total of 40,000 shares, representing 4.59% of the fund's net value, ranking as the eighth largest holding [2] - The Xiangcai Medical Health Mixed A Fund (019958) was established on December 26, 2023, with a latest scale of 13.2808 million CNY, achieving a year-to-date return of 50.36%, ranking 846 out of 8246 in its category, and a one-year return of 67.97%, ranking 1687 out of 8054 [2] Group 3 - The fund manager of Xiangcai Medical Health Mixed A Fund is Zhang Quan, who has been in the position for 1 year and 265 days, managing total assets of 18.3775 million CNY, with the best fund return during his tenure being 74.42% and the worst being 73.66% [3]

Group 1 - The core viewpoint of the news is that Zhendemedical has seen a stock price increase of 5.5%, reaching 31.07 yuan per share, with a total market capitalization of 8.279 billion yuan [1] - Zhendemedical, established on August 18, 1994, specializes in the production, research, and sales of medical dressings, with its main business revenue composition being: surgical infection control 43.04%, basic care 20.46%, stoma and modern wound care 18.59%, pressure treatment and fixation 10.75%, infection control protection 6.58%, and others 0.58% [1] Group 2 - Xiangcai Fund has a significant holding in Zhendemedical, with its Xiangcai Medical Health Mixed A Fund (019958) increasing its stake by 10,000 shares in the second quarter, bringing the total to 40,000 shares, which represents 4.59% of the fund's net value [2] - The Xiangcai Medical Health Mixed A Fund has achieved a year-to-date return of 49.12%, ranking 615 out of 8175 in its category, and a one-year return of 65.21%, ranking 1546 out of 7982 [2]